Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Date:8/1/2014

SAN DIEGO, Aug. 1, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2014.

"We have continued to see encouraging advancements in the US commercialization of BELVIQ, including a 43% quarter-over-quarter increase in estimated total prescriptions and estimated total per week prescriptions surpassing the 10,000 mark," said Jack Lief, Arena's President and Chief Executive Officer. "Other recent notable achievements consist of advancing our internally discovered pipeline and lorcaserin life-cycle management programs, and establishing a marketing and supply agreement for BELVIQ in Israel."

Second Quarter and Recent DevelopmentsBELVIQ® (lorcaserin HCl) CIV US Commercial Update

  • IMS Health estimates that approximately 110,000 prescriptions for BELVIQ were filled in the second quarter of 2014, representing growth of approximately 43% in total prescriptions as compared to the previous quarter.
  • Eisai recorded net product sales for BELVIQ of $9.9 million in the second quarter of 2014.
  • Eisai completed its planned increase of more than 200 new sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ by 50% to approximately 600. Eisai expects this further expansion of the sales force will enable them to increase their reach to a total of approximately 92,000 physicians in the United States.
  • BELVIQ Additional Developments

  • Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Teva Pharmaceutical Industries Ltd.'s local Israeli subsidiary entered into a marketing and supply agreement for BELVIQ in Israel. Under the agreement, Arena granted the rights to market and distribute BELVIQ in the territory for weight loss or weight management in obese and overwei
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
    2. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
    3. Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena
    4. Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
    5. Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference
    6. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
    7. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7
    8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    9. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference
    10. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
    11. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... YORK , March 3, 2015  PlasmaTech Biopharmaceuticals, ... advancing protein biologic therapies and oncology supportive care products, ... Annual ROTH Capital Partners Conference which is being ... Niguel in Dana Point, California.  PlasmaTech,s ... to present a corporate update on Wednesday, March 11, ...
    (Date:3/3/2015)... DENVER , March 3, 2015  Tru-D ... at the Association for Perioperative Registered Nurses, Surgical ... Colorado , during Patient Safety Awareness Week ... with resources for safe clinical practice and professional ...   Photo - http://photos.prnewswire.com/prnh/20150302/178998LOGO   ...
    (Date:3/3/2015)...  HeartIT is pleased to officially announce the ... Solution in the market which allows Viewing, Analysis, ... Precession™ combines zero footprint web technology along with ... This provides CMR professionals with a single solution ... a successful CMR program. Precession™ embraces ...
    Breaking Medicine Technology:PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3Precession Advances Medical Imaging by Delivering a Complete Cardiac Magnetic Resonance Platform in a Web Browser 2
    ... July 30 Zargis Medical Corp., a majority-owned subsidiary of ... Care System (VAPAHCS), a northern California based hospital group that ... hospitals, recently purchased 15 Zargis Cardioscan systems. , ... The VA Palo Alto Health Care System (VAPAHCS) consists ...
    ... 29 Sequenom, Inc. (Nasdaq: SQNM ), will report second quarter 2010 financial results after market close ... 1:30 pm Pacific Time ( 4:30 pm Eastern Time ) on the same day. , ... Information: , , , ... International callers: +1- 857-350-1603 , , ...
    Cached Medicine Technology:Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems 2Veterans Administration Health Care System Purchases 15 Zargis Cardioscan Systems 3Sequenom Announces Date of Second Quarter 2010 Financial Results and Conference Call 2
    (Date:3/3/2015)... Presale tickets for Madonna will be ready for purchase ... March 9, with Madonna tour tickets expected to sell out ... talented artist is a significant one for fans, and the ... Ticketability.com to browse the inventory of Madonna tickets at ... enjoy, the 2015 tour is expected to attract attention from ...
    (Date:3/3/2015)... (PRWEB) March 03, 2015 State ... prowess and prevention of probation programs aimed to ... undermines the excessive (tax) cost of incarcerating violators ... in drug and alcohol addiction treatment. Governor Bruce ... $25-$27.5 million from Illinois' drug and alcohol statewide ...
    (Date:3/3/2015)... Using an “intelligent,” rather than random, ... D prescription drug coverage plans could save Medicare and ... of Pittsburgh Graduate School of Public Health analysis discovered. ... issue of the journal Health Affairs and build upon ... more than $5 billion in its Part D low-income ...
    (Date:3/3/2015)... 2015 Volpara Solutions, leaders in the ... D. Pavlidis has joined their Board of Directors. ... executive management experience in the medical industry, including more ... organizations. , “John’s broad management experience in breast imaging ... be a tremendous asset to the sales, product marketing ...
    (Date:3/3/2015)... United Benefit Advisors (UBA), the nation’s leading ... The Gehring Group, Inc. as its newest Partner Firm. ... 20 years, The Gehring Group is a highly respected, ... firm that serves organizations in the design and implementation ... , Based in Palm Beach Gardens, Florida, and ...
    Breaking Medicine News(10 mins):Health News:Presale Tickets for Madonna: Ticketability.com Announces Madonna Tour Tickets for Sale at Reduced Prices for the Rebel Heart Tour During Presales 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 2Health News:Volpara Solutions Adds Medical Imaging Veteran John Pavlidis to Board of Directors 3Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3
    ... Boston: According to analysis of an exhaustive database on ... types of cancers//. , ,By means of a study ... that cancers of the brain, kidney and breast were the ... rest of the population. The pattern of deaths did not ...
    ... has been banned in England because the Government’s drugs rationing ... refused// to fund treatment, according to last night’s claims. ... should not be offered on the NHS to treat multiple ... of Velcade has been estimated to cost between ?9,000 and ...
    ... have found out molecules that could aid in the ... ,The expression of this molecule, sflt-1, a ... the formation of vision obstructing blood vessels, thus keeps ... this discovery could help in the development of new ...
    ... being recalled by the Irish Medicines Board due to fears ... applies to all tablets dispensed since August 29. ,As ... , they are being asked to return any unused tablets ... while pharmacies have to quarantine their unsold stocks. ,Last ...
    ... found the brain’s natural antioxidant defense mechanism to protect ... ,According to the researchers at the Dana-Farber Cancer Institute, ... effects of toxic ‘free radicals’ that are the waste ... aging and certain degenerative brain diseases, heart attack, strokes ...
    ... troubles at birth may get asthma by the time they ... ,Geir Haland and other researchers at the University of Oslo ... newborns shortly after birth and followed up after 10 years, ... ,None of the babies had severe breathing problems. But some ...
    Cached Medicine News:
    ... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
    ... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
    ... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
    ... Testing System is the smallest blood glucose testing ... when you need it in your backpack ... simply in your purse or pocket.* Its small ... go. And, because it's so convenient it's easier ...
    Medicine Products: